Table 1.
Reference | Age/Sex | Interval (Onset-Diagnosis) |
Pathology | Treatment | Outcome | Follow up |
---|---|---|---|---|---|---|
Mauney6) | 68/F | 1 wk | B cell lymphoma | RT | Alive | 3 months |
Toner7) | 59/M | 3 mo | B cell lymphoma | RT, CT (intrathecal and intravenous) | Alive | 2 years |
Klein8) | 29/F | 2 wk | B cell lymphoma | N.A. | Died | 5 weeks |
Knopp9) | 69/F | 3 wk | N.A. | N.A. | N.A. | N.A. |
Ooi10) | 16/M | 3 wk | T-lymohoblastic lymphoma | RT, CT (intrathecal and intravenous) | Died | 8 months |
Giobbia11) | 30/F | 2 mo | B cell lymphoma | RT, CT (intrathecal) | Alive | 1 year |
Zagami12) | 71/F | 3 wk | B cell lymphoma | CT (intrathecal) | Died | 16 months |
Tajima13) | 67/F | 3 yr | B cell lymphoma | RT, CT (intrathecal) | Alive | 3 years |
Khong14) | 16/M | 6 wk | B cell lymphoma | RT, CT (intravenous) | Alive | 1 year |
Morita15) | 67/M | 2 mo | NK/T cell lymphoma | RT, CT (oral) | Died | 14 months |
Beitzke23) | 69/M | 1 yr | B cell lymphoma | CT | Died | Soon after diagnosis |
Teo16) | 58/M | 2 mo | B cell lymphoma | RT, CT (intravenous) | Alive | 2 years |
Cugati17) | 11/M | 3 day | N.A. | RT, CT (intravenous) | Alive | 1 year |
Iwasaki18) | 69/M | N.A. | B cell lymphoma | RT, CT (intravenous) | Died | 1.5 years |
Nishida19) | 47/M | 10 day | B cell lymphoma | RT, CT (intrathecal and intravenous) | Alive | 1.5 years |
Nakashima (this study) |
59/M | 7 mo | B cell lymphoma | RT, CT (intravenous) | Alive | 1 year |
N.A., not available; RT, radiation therapy; CT, chemotherapy